CA2107329C - Anticorps recombinants anti-virus de l'immunodeficience humaine - Google Patents

Anticorps recombinants anti-virus de l'immunodeficience humaine

Info

Publication number
CA2107329C
CA2107329C CA002107329A CA2107329A CA2107329C CA 2107329 C CA2107329 C CA 2107329C CA 002107329 A CA002107329 A CA 002107329A CA 2107329 A CA2107329 A CA 2107329A CA 2107329 C CA2107329 C CA 2107329C
Authority
CA
Canada
Prior art keywords
combining site
immunoglobulin molecule
cell
cells
cell epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002107329A
Other languages
English (en)
Other versions
CA2107329A1 (fr
Inventor
Bona Constantin
Zaghouani Habib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of CA2107329A1 publication Critical patent/CA2107329A1/fr
Application granted granted Critical
Publication of CA2107329C publication Critical patent/CA2107329C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention décrit des anticorps hybrides comprenant une partie de base correspondant à la partie constante de l'immunoglobuline G chez l'homme, un site de combinaison sélectionné pour sa spécificité à l'antigène cible particulier et un site de combinaison se fixant aux lymphocytes T cytotoxiques humains et activant ceux-ci.
CA002107329A 1991-04-18 1992-04-10 Anticorps recombinants anti-virus de l'immunodeficience humaine Expired - Fee Related CA2107329C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68737691A 1991-04-18 1991-04-18
US07/687,376 1991-04-18
PCT/US1992/002975 WO1992018540A1 (fr) 1991-04-18 1992-04-10 Anticorps recombines anti-vih

Publications (2)

Publication Number Publication Date
CA2107329A1 CA2107329A1 (fr) 1992-10-19
CA2107329C true CA2107329C (fr) 1999-04-27

Family

ID=24760226

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002107329A Expired - Fee Related CA2107329C (fr) 1991-04-18 1992-04-10 Anticorps recombinants anti-virus de l'immunodeficience humaine

Country Status (6)

Country Link
EP (1) EP0580758A4 (fr)
JP (1) JPH06506947A (fr)
AU (1) AU672580B2 (fr)
CA (1) CA2107329C (fr)
IL (1) IL101602A (fr)
WO (1) WO1992018540A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0460076T3 (da) * 1989-02-24 1996-03-25 Univ California Genetisk manipulerede immunoglobuliner
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
GB0102145D0 (en) * 2001-01-26 2001-03-14 Scancell Ltd Substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850542T2 (de) * 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
WO1993019180A1 (fr) * 1992-03-17 1993-09-30 Ciba-Geigy Ag Anticorps produits par genie genetique
EP0570357B1 (fr) * 1992-05-14 1997-06-25 Polymun Scientific Immunbiologische Forschung GmbH Peptides induisant des anticorps, qui neutralisent des isolées d'HIV-1 qui divergent génétiquement

Also Published As

Publication number Publication date
CA2107329A1 (fr) 1992-10-19
EP0580758A1 (fr) 1994-02-02
AU1891992A (en) 1992-11-17
IL101602A0 (en) 1992-12-30
IL101602A (en) 1996-10-31
AU672580B2 (en) 1996-10-10
EP0580758A4 (fr) 1995-04-05
WO1992018540A1 (fr) 1992-10-29
JPH06506947A (ja) 1994-08-04

Similar Documents

Publication Publication Date Title
US5969109A (en) Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
WO1996019584A9 (fr) Anticorps chimeres comprenant des sites de liaison a l'antigene et des epitopes des lymphocytes b et t
JP3855071B2 (ja) 抗ｈｉｖモノクローナル抗体
US5658762A (en) DNA molecules, expression vectors and host cells expressing antigenized antibodies
JP3786695B2 (ja) 修飾した抗原性免疾グロブリンによるｔ細胞の活性化
JP4214173B2 (ja) 寛容原性融合タンパク質による寛容性の誘発
EP0380068B1 (fr) Système d'expression pour la production d'anticorps monoclonaux chimériques
Zaghouani et al. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells
WO1992007574A1 (fr) Glycoproteines associees a des immunoglobulines a liaison membranaire et utilisees comme cibles anticorpales sur des cellules b
JPWO1994020632A1 (ja) 抗ｈｉｖモノクローナル抗体
JPH03504556A (ja) Ｈｉｖ‐１を中和するモノクローナル抗体
JPH05336989A (ja) 抗体誘導体
HUE035617T2 (en) Anti-CSF-1R antibody
KR102784691B1 (ko) Il-12 및 항-cd20 항체를 포함하는 융합단백질 및 이의 용도
AU2002225230B2 (en) Polypeptides capable of binding to CD64 and comprising one or more heterologous T cell epitopes, and their uses
Kang et al. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
AU672580B2 (en) Chimeric immunoglobulin molecules
WO2003059953A2 (fr) Anticorps anti-idiotypique induisant les anticorps neutralisant le vih-1
JP2583555B2 (ja) ヒト免疫不全ウイルス（ｈｉｖ）の検出と治療のための方法および物質
CA2145064C (fr) Ameliorations de la modification de la reponse immunitaire ou concernant celle-ci
Geisberg et al. Monoclonal antibodies detecting discrete epitopes of human perforin
Moran et al. A novel technique for the production of hybrid antibodies
Weissenhorn et al. Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the α-chain of the human interleukin-2 receptor
JPH08510912A (ja) 遺伝子処理された免疫グロブリン
CA2157874C (fr) Anticorps monoclonal anti-vih

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed